Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Review Article (Mini-Review)

Endogenous Enzyme-responsive Nanoplatforms for Anti-tumor Therapy

Author(s): Xue-Fang Lou, Yong-Zhong Du and Xiao-Ling Xu*

Volume 22 , Issue 8 , 2021

Published on: 14 January, 2021

Page: [845 - 855] Pages: 11

DOI: 10.2174/1389450122666210114095614

Price: $65

Abstract

The emergency of responsive drug delivery systems has contributed to reduced cytotoxicity, improved permeability in tissues and extended circulation time of the active drug. In particular, enzyme-responsive nanoplatforms have attracted a lot of attention due to the specificity and efficiency of an enzyme-catalyzed reaction. In this review, enzyme-based mono responsive drug delivery systems designed in the past 5 years have been summarized. These drug delivery systems were introduced by different tumor-related enzymes such as matrix metalloproteinase, esterase, hyaluronidase, caspase and cathepsin. Moreover, the enzyme-sensitive nanoplatforms activated by dual-stimuli have been also described. Although great progress had been made in the past years, the translation into clinical practice is still difficult. Thus, three obstacles (enzyme heterogeneity, reaction environment, animal model) were also discussed. In short, enzyme-activated drug delivery systems offer great potential in treating cancers.

Keywords: Enzyme-responsive, matrix metalloproteinase, esterase, hyaluronidase, caspase, cathepsin.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy